top of page
Blog 012: Unlocking Skin's Potential: Formulation Strategies for Enhanced Topical Pharmaceutical Pen
Introduction: In the realm of pharmaceuticals, delivering therapeutic agents through the skin offers a myriad of benefits, from localized...
Team Calatheas
Dec 2, 20232 min read
Â
Â
Â


Blog 009: FDA Warning Letters: Extracting Lessons Learned and Strategies for Compliance Excellence
In the regulated world of pharmaceuticals, FDA Warning Letters serve as crucial indicators of areas where companies have fallen short of...
Team Calatheas
Nov 29, 20233 min read
Â
Â
Â


Blog 011:Exploring the Impact of the Drug Competition Action Plan (DCAP) on Generic Drug Development
In the realm of pharmaceuticals, the landscape is constantly evolving, driven by the need for innovation, accessibility, and...
Team Calatheas
Nov 17, 20233 min read
Â
Â
Â


Blog 010: Biosimilars: Navigating the Regulatory Landscape in the United States
In the intricate world of biopharmaceuticals, biosimilars have emerged as a transformative force, offering the potential for increased...
Team Calatheas
Oct 9, 20233 min read
Â
Â
Â


Blog 008: The FDA's Accelerated Approval Program: Navigating Opportunities and Challenges
In the fast-paced world of pharmaceutical development, where patient needs are urgent and unmet, the United States Food and Drug...
Team Calatheas
Aug 26, 20233 min read
Â
Â
Â


Blog 007: The Crucial Role of Pharmacovigilance in FDA Compliance and Drug Safety
In the intricate landscape of pharmaceuticals, ensuring the safety of drugs once they reach the market is paramount. The United States...
Team Calatheas
Jul 25, 20233 min read
Â
Â
Â


Blog 006: Addressing Common Challenges in USFDA Compliance for Pharmaceutical Manufacturing
Addressing Common Challenges in USFDA Compliance for Pharmaceutical Manufacturing Pharmaceutical manufacturing is a complex and highly...
Team Calatheas
Jun 9, 20233 min read
Â
Â
Â


Blog 005: Navigating the USFDA Inspection Process: Best Practices for Pharma Companies
Navigating the USFDA Inspection Process: Best Practices for Pharma Companies In the highly regulated world of pharmaceuticals, a visit...
Team Calatheas
May 16, 20233 min read
Â
Â
Â


Blog 004: A Comprehensive Guide to the FDA Approval Process for Pharmaceutical Developers
A Comprehensive Guide to the FDA Approval Process for Pharmaceutical Developers In the expansive realm of pharmaceutical development, the...
Team Calatheas
Apr 26, 20233 min read
Â
Â
Â


Blog 003: Recent Transformations in USFDA Regulations & Impact on Pharma
Navigating the Winds of Change: Recent Transformations in USFDA Regulations and Their Impact on Pharma Companies In the dynamic landscape...
Team Calatheas
Mar 12, 20233 min read
Â
Â
Â


Blog 002: The Pillars of Safety: Unveiling the Role of USFDA in Ensuring Drug Safety and Efficacy
Introduction: In the ever-evolving landscape of pharmaceuticals, where innovation and patient well-being intersect, the United States...
Team Calatheas
Feb 24, 20232 min read
Â
Â
Â


Blog 001: NITROSAMINE IMPURITY in Pharmaceutical Products
Navigating the Challenge of Pharmaceutical Nitrosamine Impurity: Strategies for Avoidance, Testing, and Product Development In recent...
Team Calatheas
Jan 14, 20232 min read
Â
Â
Â
bottom of page
